|
|
|
|
| LEADER |
01892nam a22003015i 4500 |
| 001 |
978-3-540-34344-8 |
| 005 |
20191025132403.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2007 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783540343448
|
| 024 |
7 |
|
|a 10.1007/978-3-540-34344-8
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Kaposi Sarcoma Herpesvirus: New Perspectives
|c edited by Chris Boshoff, R.A. Weiss.
|
| 250 |
|
|
|a 1st ed. 2007.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2007.
|
| 300 |
|
|
|a XV, 332 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Current Topics in Microbiology and Immunology,
|v 312
|
| 505 |
0 |
|
|a Modern Evolutionary History of the Human KSHV Genome -- Rhesus Monkey Rhadinovirus: A Model for the Study of KSHV -- The Rta/Orf50 Transactivator Proteins of the Gamma-Herpesviridae -- Structure and Function of Latency-Associated Nuclear Antigen -- The KSHV and Other Human Herpesviral G Protein-Coupled Receptors -- Regulation of KSHV Lytic Gene Expression -- Kaposi Sarcoma Herpesvirus-Encoded Interferon Regulator Factors -- Endothelial Cell- and Lymphocyte-Based In Vitro Systems for Understanding KSHV Biology -- KSHV After an Organ Transplant: Should We Screen? -- Kaposi Sarcoma-Associated Herpesvirus and Other Viruses in Human Lymphomagenesis -- The Use of Antiviral Drugs in the Prevention and Treatment of Kaposi Sarcoma, Multicentric Castleman Disease and Primary Effusion Lymphoma -- Interactions Between HIV-1 Tat and KSHV.
|
| 650 |
|
0 |
|a Virology.
|
| 650 |
1 |
4 |
|a Virology.
|
| 700 |
1 |
|
|a Boshoff, Chris.
|e editor.
|
| 700 |
1 |
|
|a Weiss, R.A.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-540-34344-8
|